$VTIX earnings report

Virtuix Q2 FY2027 net sales rose 21% year-over-year to $1.2 million on Omni One growth, but net loss widened to $(6.4) million and the filing carries going-concern doubt. AlphAI read Virtuix Holdings's Q2 fiscal 2027 filing as weak. 2 quarters are on record below.

Q2 fiscal 2027

AlphAI · Earnings readVTIX · Q2 fiscal 2027 · ended 2026-09-30

Virtuix Q2 FY2027 net sales rose 21% year-over-year to $1.2 million on Omni One growth, but net loss widened to $(6.4) million and the filing carries going-concern doubt

↓Weak quarter

Revenue grew (net sales up 21% year-over-year and 55% sequentially, Omni One up 105%), but gross margin fell from 41% to 25% as the company states, total operating expenses rose to $5,132,655 from $1,942,317, net loss was $(6,367,511) against $(1,866,696), Adjusted EBITDA loss widened to $(3,637,199), cash fell to $4,963,127, and the filing discloses substantial doubt about the going-concern assumption, a Nasdaq compliance deadline and a material weakness.

Revenue
$1,190,097
21% y/y · 55% q/q
Omni One
$1.1 million (three months ended Sep 30, 2026)
105% y/y
Gross margin · GAAP
25%
EPS · GAAP
$(0.19)

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net sales (three months ended Sep 30, 2026)GAAP$1,190,09755%21%
Omni One sales (three months ended Sep 30, 2026)other$1.1M–105%
Omni One share of total revenue (three months ended Sep 30, 2026)other93%––
Legacy Omni Arena sales change (three months ended Sep 30, 2026)other$0.3 million decline––
Omni One unit orders (year-over-year multiple, three months ended Sep 30, 2026)other3.3X––
Omni One Enterprise orders (year-over-year increase, three months ended Sep 30, 2026)other45%––
Cost of goods sold (three months ended Sep 30, 2026)GAAP$894,898––
Gross profit (three months ended Sep 30, 2026)GAAP$295,19930%–
Gross margin (three months ended Sep 30, 2026)GAAP25%––
Selling expenses (three months ended Sep 30, 2026)GAAP$924,457––
General and administrative expenses (three months ended Sep 30, 2026)GAAP$4,005,950––
Research and development expenses (three months ended Sep 30, 2026)GAAP$202,248––
Total operating expenses (three months ended Sep 30, 2026)GAAP$5,132,655––
Loss from operations (three months ended Sep 30, 2026)GAAP$(4,837,456)––
Interest expense (three months ended Sep 30, 2026)GAAP$(2,047,820)––
Financing expense (three months ended Sep 30, 2026)GAAP$(426,249)––
Change in fair value of derivative liabilities (three months ended Sep 30, 2026)GAAP$667,554––
Total other expense, net (three months ended Sep 30, 2026)GAAP$(1,505,243)––
Net loss (three months ended Sep 30, 2026)GAAP$(6,367,511)––
Net loss per share, basic and diluted (three months ended Sep 30, 2026)GAAP$(0.19)––
EBITDA (three months ended Sep 30, 2026)non-GAAP$(4,135,390)––
Adjusted EBITDA loss (three months ended Sep 30, 2026)non-GAAP$(3,637,199)––
Net sales (six months ended Sep 30, 2026)GAAP$1,957,397––
Cost of goods sold (six months ended Sep 30, 2026)GAAP$1,435,040––
Gross profit (six months ended Sep 30, 2026)GAAP$522,357––
Total operating expenses (six months ended Sep 30, 2026)GAAP$9,261,786––
Loss from operations (six months ended Sep 30, 2026)GAAP$(8,739,429)––
Total other expense, net (six months ended Sep 30, 2026)GAAP$(4,724,445)––
Net loss (six months ended Sep 30, 2026)GAAP$(13,538,077)––
Net loss per share, basic and diluted (six months ended Sep 30, 2026)GAAP$(0.41)––
EBITDA (six months ended Sep 30, 2026)non-GAAP$(8,574,183)––
Adjusted EBITDA loss (six months ended Sep 30, 2026)non-GAAP$(6,710,031)––
Cash used in operating activities (six months ended Sep 30, 2026)GAAP$(6,857,206)––
Net (decrease) increase in cash and cash equivalents (six months ended Sep 30, 2026)GAAP$(4,508,161)––

Segments

SegmentRevenueq/qy/y
Omni OneThe release states the increase was primarily driven by the launch of Omni One for Quest in collaboration with Meta Platforms, Inc. Omni One represented 93% of total revenue, per the release.$1.1 million (three months ended Sep 30, 2026)–105%
Legacy Omni ArenaThe release states that the decline partially offset Omni One sales growth. The filing gives no revenue total for this line.Not printed as a figure. The release states a $0.3 million decline in legacy Omni Arena sales.––

Capital returns

  • The filing reports no share repurchases and no dividends.
  • Warrant exercises: the release states $2.6 million in gross proceeds from warrant exercises during the six months ended September 30, 2026. The cash flow statement prints warrants exercised of 2,561,250 for the six months ended September 30, 2026.
  • Equity issuance costs of (179,287) are printed in the six-month cash flow statement for the six months ended September 30, 2026.

What drove it

  • Omni One sales rose 105% to $1.1 million, which the company attributes primarily to the launch of Omni One for Quest in collaboration with Meta Platforms, Inc.
  • Omni One unit orders increased 3.3X year-over-year, and Omni One Enterprise orders increased 45% year-over-year, per the release.
  • Gross margin of 25% against 41% a year ago reflects, according to the release, a shift in sales mix toward Omni One from higher-margin Omni Arena products and services.
  • Total operating expenses of $5.1 million against $1.9 million rose, according to the release, primarily reflecting non-cash stock-based compensation, increased marketing investments to build the 2026 Holiday sales funnel, and higher general and administrative expenses associated with operating as a public company, including professional services and insurance costs.
  • Total other expense, net of $1.5 million against $0.3 million reflects, according to the release, non-cash debt-related amortization and warrant modification expenses, partially offset by non-cash gains from changes in the fair value of financial instruments.
  • The release states that the net loss increase was driven primarily by higher non-cash financing expenses and higher professional services expenses related to operating as a publicly traded company.
  • The release states that the net loss of $(6.4) million narrowed from $(7.2) million in the first quarter of fiscal 2027.
  • The company states that prior-period amounts have been revised to correct immaterial errors related to the accounting for certain financing arrangements.

Concerns

  • The filing states there is substantial doubt regarding the Company's ability to continue as a going concern, and that it needs additional financing to fund planned operations over the next 12 months.
  • Cash and cash equivalents fell to $4,963,127 from $9,471,288 at March 31, 2026, and net cash used in operating activities for the six months was $(6,857,206).
  • The release gives an Adjusted EBITDA loss of $(3,637,199) for the quarter against $(1,172,004) in the prior-year quarter. The six-month figure is $(6,710,031) against $(3,044,090).
  • Gross margin fell to 25% from 41% a year ago, and the release describes the shift toward Omni One as the reason.
  • Gross profit sentence in the release reads 'increased 30% sequentially to $0.3 million, compared to $0.4 million in the prior-year period', while the statement of operations prints gross profit of $295,199 against $407,549 in the prior-year quarter. The figures are reported as printed.
  • Pre-paid purchase arrangements with Streeterville Capital, LLC: the filing lists potential substantial dilution, a requirement to make cash payments if the purchase price remains below the $2.00 floor price for six consecutive months, which could occur as early as late January 2027, and the company's current inability to obtain additional pre-paid purchases.
  • The company must regain compliance with The Nasdaq Global Market's minimum market value of listed securities requirement by March 29, 2027. The filing lists a potential event of default and acceleration of amounts owed under the pre-paid purchase arrangements if delisted.
  • The filing discloses a material weakness in internal control over financial reporting related to the accounting for complex financing transactions, which resulted in revisions to previously reported financial information.
  • For the proposed STS International acquisition, the release states the cash portion of consideration (approximately $8 million) requires financing, and the filing says the company has no committed financing for it.
  • STS International financial information is unaudited and cash-basis, and the release states the amounts may differ materially from audited GAAP statements.
  • The filing states that meaningful defense sales may not materialize until fiscal year 2028 at the earliest, if at all.

What to watch

  • Whether Omni One revenue growth continues and whether gross margin recovers from 25% as the mix shifts.
  • Whether the company's stated cost reductions in accounting, investor relations and operational overhead reduce operating expenses, given the CFO's statement that the company expects cash burn to decline.
  • Going-concern status, financing actions and any use of the Streeterville pre-paid purchase arrangements, including the $2.00 floor price test that could occur as early as late January 2027.
  • Regaining compliance with Nasdaq's minimum market value of listed securities requirement by March 29, 2027.
  • Progress on the non-binding LOI for STS International, including definitive agreements, the audit of STS financial statements, the fairness opinion, financing for the cash consideration, and the intended closing during the fiscal year ending March 31, 2027.
  • Remediation of the material weakness in internal control over financial reporting.
  • The Omni One Enterprise and government customer pipeline, the Phase II AFWERX SBIR proposal, and the early 2027 start of the multi-site autism therapy pilot.

Balance sheet and cash flow

  • Cash and cash equivalents: $4,963,127 at September 30, 2026, against $9,471,288 at March 31, 2026, as printed on the balance sheet. The release describes this as $5.0 million against $9.5 million.
  • Total assets: $10,112,263 at September 30, 2026, against $14,761,370 at March 31, 2026 (As Revised).
  • Total liabilities: $16,289,115 at September 30, 2026, against $13,664,618 at March 31, 2026 (As Revised), with the balance sheet column order as printed.
  • Total stockholders' (deficit) equity: $(6,176,852) at September 30, 2026, against $1,096,752 at March 31, 2026 (As Revised).
  • Derivative liabilities at fair value: $2,709,817 at September 30, 2026, against $1,233,095 at March 31, 2026.
  • Notes payable measured under the fair value option, PPP #2: $3,610,158 at March 31, 2026 and no balance printed for September 30, 2026.
  • Net cash used in operating activities for the six months ended September 30, 2026 was $(6,857,206), against $(3,636,689) in the prior-year six months.
  • Net loss for the six months includes non-cash amortization of debt discounts and debt issuance costs of 4,140,678 and warrant modification expense of 1,010,399 per the cash flow statement.

Analysis

Virtuix reported second-quarter fiscal 2027 net sales of $1,190,097, up 21% from $984,812 a year earlier and up 55% sequentially, per the release. Omni One sales rose 105% to $1.1 million, which the company attributes to the launch of Omni One for Quest with Meta Platforms, Inc. Omni One represented 93% of total revenue, and the release describes a $0.3 million decline in legacy Omni Arena sales that partially offset that growth. Unit orders rose 3.3X year-over-year and Enterprise orders rose 45%, so the order data points in the same direction as revenue.

Profitability moved the other way. Gross margin fell to 25% from 41% a year earlier, and the release attributes this to a shift in sales mix toward Omni One from higher-margin Omni Arena products and services. Total operating expenses rose to $5,132,655 from $1,942,317, and the company attributes this mainly to non-cash stock-based compensation, Holiday-season marketing and public-company G&A. Loss from operations was $(4,837,456) against $(1,534,768). Total other expense, net was $(1,505,243) against $(331,175), and the release links it to non-cash debt-related amortization and warrant modification expenses, partly offset by non-cash fair-value gains. Net loss was $(6,367,511), or $(0.19) per share, against $(1,866,696), or $(0.09) per share. The release states the quarterly loss narrowed from $(7.2) million in the first quarter. Adjusted EBITDA loss was $(3,637,199) against $(1,172,004), a non-GAAP measure that the filing reconciles to GAAP net loss.

The balance sheet and cash flow data carry the main risk. Cash and cash equivalents were $4,963,127 at September 30, 2026, against $9,471,288 at March 31, 2026. Net cash used in operating activities for the six months was $(6,857,206), and the company received $2.6 million in gross proceeds from warrant exercises in the period. Total stockholders' deficit was $(6,176,852) at September 30, 2026, against equity of $1,096,752 at March 31, 2026 (As Revised). The filing states substantial doubt about the going-concern assumption, and it discloses a pre-paid purchase arrangement with Streeterville Capital, LLC, a $2.00 floor-price test, a Nasdaq compliance deadline of March 29, 2027 and a material weakness in internal control.

The release presents the proposed STS International acquisition as a step into defense. It is a non-binding LOI with base consideration of approximately $12 million, comprising approximately $8 million in cash and $4 million in Class A shares. The company states it has no committed financing for the cash portion. STS reported unaudited, cash-basis revenue of approximately $6.7 million for 2025 and approximately $40 million for the first 10 months of 2026, and the release states these figures may differ materially from GAAP audited statements. The filing also states that meaningful defense sales may not materialize until fiscal 2028 at the earliest, if at all.

The filing provides no quantitative guidance for the next period and no consensus or share-price reaction data, so the guide cannot be compared to expectations. The read therefore rests on the reported quarter: revenue and order growth are visible, but gross margin, operating costs, net loss and cash position all moved against the company during the period, and the filing's financing and listing disclosures remain open.

Management, verbatim

Our second quarter demonstrates that Virtuix's commercial strategy is gaining traction. Omni One revenue more than doubled, unit orders increased 3.3 times, and Enterprise orders grew 45%, reflecting increasing adoption across consumer and professional markets

Jan Goetgeluk, Founder, Chairman and Chief Executive Officer

We expect cash burn to decline as revenue grows and we implement these cost-saving measures.

Thomas McGinnis, Chief Financial Officer

Not in the filing

stated, not guessed
  • No quantitative forward guidance for revenue, gross margin, operating expenses or tax rate is printed in the filing.
  • No analyst consensus, price target or share-price reaction is provided in the documents.
  • No previous-period outlook was provided, so the vs_prior_guidance comparison could not be made.
  • No segment results table is printed. Legacy Omni Arena revenue is given only as a $0.3 million decline, with no revenue total.
  • Prior-quarter (first quarter fiscal 2027) figures for cost of goods sold, gross profit, gross margin and operating expense lines are not printed in the filing.
  • The change in gross margin in basis points is not printed; only the 25% and 41% margins are given.
  • Year-over-year changes for cost of goods sold, operating expense lines, net loss and EPS are not printed as percentages in the filing.
  • Year-over-year percentage changes for the six-month period are not printed.
  • Omni One gross profit or margin is not printed.
  • Cash balance of $9,471,288 is at March 31, 2026, the prior fiscal year end, not at the prior quarter end, so it is not placed in the prior_quarter field.
  • The financing expense prior-year value is shown as a dash in the statement of operations and is left null.
  • STS International's 2025 revenue is given as approximately $6.7 million on an unaudited, cash-basis basis, and its 2026 figures are not audited.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

First quarter fiscal year 2027

AlphAI · Earnings readVTIX · First quarter fiscal year 2027 · ended June 30, 2026

Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch

→Mixed quarter

New Omni One orders increased 72% year-over-year, gross profit increased 29%, and gross margin expanded to 30% from 17%, but net sales declined 26%, operating expenses rose 86%, net loss widened to ($7.2) million, adjusted EBITDA loss widened, and cash declined to $7.4 million.

Revenue
$800K
26% decrease y/y
Gross margin · GAAP
30%
expanded to 30% from 17% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net salesGAAP$800K–26% decrease
SalesGAAP$767,300–26% decrease
New orders for Omni One systemsotherincreased 72%–increased 72%
New orders for Omni One systems since launch of Omni One for Questotherincreased approximately 150%–increased approximately 150% since the launch of Omni One for Quest compared to the same period last year
Cost of goods soldGAAP$540,142––
Gross profitGAAP$227,158–increased 29%
Gross marginGAAP30%–expanded to 30% from 17%
Selling expensesGAAP$738,978––
General and administrative expensesGAAP$3,080,778––
Research and development expensesGAAP$309,375––
Total operating expensesGAAP$4.1M–increased by $1.9 million, or 86%
Loss from operationsGAAP($3,901,973)––
Total other expense, netGAAP($3.2 million)––
Interest expenseGAAP($2,539,592)––
Financing expenseGAAP($584,150)––
Loss on extinguishment of debtGAAP($431,224)––
Provision for income taxGAAP$49,391––
Net lossGAAP($7.2) million––
Net lossGAAP($7,170,566)––
Net loss per basic and diluted shareGAAP($0.22)–narrowed from ($0.28) to ($0.22) per share
Weighted average common shares outstanding, basic and dilutedGAAP32,787,960––
Adjusted EBITDA lossnon-GAAP($3.1) million––
Adjusted EBITDAnon-GAAP($3,072,832)––
Cash used in operating activitiesGAAP($3,294,829)––
Cash used in investing activitiesGAAP($11,247)––
Cash provided by financing activitiesGAAP$1,278,657––
Net decrease in cashGAAP($2,027,419)––
Cash and cash equivalentsGAAP$7,443,869––
Current portion of notes payable, net of discount and unamortized deferred loan costsGAAP$9,658,998––
Notes payable, net of discount and unamortized deferred loan costsGAAP$1,039,518––
Total liabilitiesGAAP$15,660,981––
Total stockholders' (deficit) equityGAAP($3,080,495)––

What drove it

  • Current-quarter revenue was generated from newly acquired customers, while the prior-year period benefited from fulfillment of the final batch of legacy Omni One preorder backlog accumulated since August 2023.
  • New orders for Omni One systems increased 72% year-over-year, with approximately 150% growth since the launch of Omni One for Quest.
  • Gross-margin expansion primarily reflected the higher selling price of the complete Omni One system compared with units delivered in the prior-year period.
  • The company delivered an Omni One system to the Pennsylvania Air National Guard, its first deployment with the Air National Guard.
  • Virtuix sold its first Omni One Enterprise system to Tesla, Inc. for the Optimus humanoid robot division's teleoperation use.
  • Virtuix was awarded U.S. Air Force funding under Phase I of the AFWERX SBIR program for its Virtual Terrain Walk platform.

Concerns

  • Net sales declined 26% to $0.8 million from $1.0 million.
  • Total operating expenses increased by $1.9 million, or 86%, to $4.1 million, driven primarily by a non-cash $0.7 million increase in stock compensation expense and a $1.2 million increase in public-company professional services fees.
  • Net loss widened to ($7.2) million from ($2.3) million, primarily reflecting $4.0 million of non-cash charges and higher operating expenses.
  • Adjusted EBITDA loss widened to ($3.1) million from ($1.9) million.
  • Interest expense was ($2,539,592), including $2,052,255 of non-cash amortization of debt discount related to financing arrangements.
  • The filing cites limited cash runway and substantial doubt regarding the company's ability to continue as a going concern, as disclosed in its latest Quarterly Report on Form 10-Q.
  • The company identifies the need for additional capital and the ability to meet convertible note and other debt obligations when due as risks.

What to watch

  • Whether the reported 72% year-over-year growth in new Omni One orders converts into accelerating revenue growth.
  • Delivery of the U.S. Marine Corps Infantry Fireteam Trainer pilot system to Quantico, VA, expected in the fourth calendar quarter of 2026.
  • Results of the U.S. Marine Corps evaluation of LeadTech's Counter-UAS Personnel Trainer and potential AFWERX SBIR Phase II and Phase III funding.
  • Progress on acquisition opportunities in defense training and simulation involving companies with annual revenues in the $10 million to $50 million range.
  • Potential joint marketing and bundling opportunities under the Meta collaboration.
  • Execution of enterprise deployments with Tesla, NASA's year-long MMEA study beginning in 2027, and Sirica Therapeutics' plan to establish approximately 100 treatment centers nationwide.

Balance sheet and cash flow

  • Cash and cash equivalents totaled $7.4 million as of June 30, 2026, compared to $9.5 million as of March 31, 2026.
  • Cash used in operating activities was ($3,294,829), compared to ($1,491,122) in the prior-year period.
  • Cash used in investing activities was ($11,247), compared to ($3,496) in the prior-year period.
  • Cash provided by financing activities was $1,278,657, including $1,380,000 from warrants exercised and ($96,600) of equity issuance costs.
  • Current portion of notes payable, net of discount and unamortized deferred loan costs, was $9,658,998 as of June 30, 2026.
  • Total liabilities were $15,660,981 and total stockholders' (deficit) equity was ($3,080,495) as of June 30, 2026.

Analysis

Virtuix reported a split first quarter. Net sales declined 26% to $0.8 million from $1.0 million, but management attributed the prior-year revenue to fulfillment of the final batch of legacy preorder backlog accumulated since August 2023. The current quarter's revenue came from newly acquired customers, while new orders for Omni One systems rose 72% year-over-year and approximately 150% since the launch of Omni One for Quest. Management stated that similar order momentum continued into the current quarter.

Product economics improved despite the lower reported sales base. Gross profit rose 29% to $227,158 from $176,077, and gross margin expanded to 30% from 17%. The company attributed the improvement primarily to a higher selling price for the complete Omni One system than the price of units delivered in the prior-year quarter. The filing does not report revenue by consumer, defense, enterprise, or healthcare segment, so the financial contribution from the new Tesla, Air National Guard, Sirica, and other deployments cannot be quantified.

Costs and financing charges drove substantially wider losses. Operating expenses increased 86% to $4.1 million, led by a non-cash $0.7 million increase in stock compensation expense and a $1.2 million increase in public-company professional-services costs. Total other expense was $3.2 million, including $2.5 million of interest expense and non-cash amortization of debt discount associated with convertible notes. GAAP net loss widened to ($7.2) million from ($2.3) million, while adjusted EBITDA loss widened to ($3.1) million from ($1.9) million. Basic and diluted net loss per share nevertheless narrowed to ($0.22) from ($0.28), alongside weighted-average shares of 32,787,960 versus 8,259,732.

Cash and financing remain central considerations. Cash and cash equivalents were $7.4 million at June 30, 2026, down from $9.5 million at March 31, 2026. The company used ($3.3) million in operating activities and received $1.3 million from financing activities, including $1.4 million from warrants exercised. Current notes payable, net of discount and unamortized deferred loan costs, were $9.7 million, and stockholders' equity moved to a ($3.1) million deficit from $1.1 million as of March 31, 2026. The filing explicitly identifies limited cash runway, substantial doubt regarding going concern, additional-capital needs, and debt obligations as risks.

Operationally, Virtuix is broadening Omni One's use cases across defense, robotics, healthcare, and consumer markets. The company cited its first Tesla Optimus sale, a first Air National Guard deployment, U.S. Air Force Phase I AFWERX SBIR funding, progress on the Marine Corps Infantry Fireteam Trainer, NASA MMEA selection for a study beginning in 2027, and two systems shipped to Sirica Therapeutics. Management also said its special committee is reviewing defense-sector acquisitions. No formal financial guidance was provided, leaving conversion of higher orders into revenue, defense-program progression, financing capacity, and acquisition execution as the principal disclosed items to monitor.

Management, verbatim

The first quarter of fiscal 2027 was one of the strongest commercial quarters in our Company’s recent history.

Jan Goetgeluk, CEO of Virtuix

While reported revenue was lower year-over-year, that comparison reflects the completion of our legacy preorder backlog: revenue in the prior-year period was driven largely by the fulfillment of the final batch of the large backlog of Omni One orders accumulated since the start of our preorder period in August 2023, whereas revenues this quarter resulted from sales to newly acquired customers.

Jan Goetgeluk, CEO of Virtuix

Our unit economics also continued to improve. Gross profit increased 29% year-over-year and gross margin expanded to 30% from 17%, primarily reflecting the higher selling price of the complete Omni One system in the first quarter of fiscal 2027 compared to the price of units delivered in the prior-year period.

Jan Goetgeluk, CEO of Virtuix

Not in the filing

stated, not guessed
  • Formal quantified financial guidance for revenue, gross margin, operating expenses, tax rate, earnings, cash flow, or capital expenditures
  • Previous-quarter outlook for comparison with actual results
  • Revenue by reportable segment or by consumer, defense, enterprise, and healthcare end market
  • Non-GAAP earnings per share
  • Free cash flow
  • Capital-return program information, including share repurchases or dividends
  • Tax rate
  • Total debt stated as a single consolidated figure

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about VTIX earnings dates

When is Virtuix Holdings's next earnings date?
AlphAI has no date for VTIX yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.